Nonjudgmental services and innovative ways to talk to youth about sex should be at the core of any sexual health plan.
Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.
Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results
Newly presented data from IAS 2019 spark discussion about study populations, study endpoints, and potential weight gain.
But given cost concerns, advocates question whether the benefits are enough to warrant dumping F/TDF as the go-to PrEP option.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Brief IAS 2017 summaries of ongoing research on pre-exposure prophylaxis (PrEP), evaluating its long-term effectiveness and safety, patient experiences, and alternative dosing schedules, such as an on-demand regimen.
PrEP is not intended for life, but as a way to bridge "seasons of risk" when people may be at a higher risk of contracting HIV, says Robert Grant, M.D., M.P.H., of the Gladstone Institutes.
Two studies presented at IAS 2015 offered a look at factors associated with adherence to PrEP in men who have sex with men (MSM).